1. OP0263 Efficacy and safety of GLPG0634, a selective JAK1 inhibitor, after short-term treatment of rheumatoid arthritis; results of a phase IIA trial. (23rd January 2014) Authors: Vanhoutte, F.P.; Mazur, M.; Namour, F.; van der Aa, A.; Wigerinck, P.; van 't Klooster, G.A.E. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 145 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗